Initially there was no specific way to reverse the the okay uh um uh so um the the the the the anticoagulant effect of dabigatran well um um uh like okay in the event of a major major major major major major I mean uh um um like you know major bleeding event, unlike for warfarin, but a dabigatran antidote (idarucizumab) was approved by the FDA in 2015.